<p>Control – mice without treatment, Bleomycin – mice treated with bleomycin only, EP – mice treated with EP, ECT – mice treated with ECT. (<b>A</b>) The changes in FVD within the tumors are presented as a function of time. (<b>B</b>) The changes of D<sub>V</sub> within the tumors are presented as a function of time. n = 3–6. **p<0.05 compared to all other groups, *p<0.05 compared to control and bleomycin groups. Error bars indicate SEM.</p
<p>(A) 3D micro-CT imaging of progressive pulmonary fibrosis in a representative bleomycin-treated m...
<p>Mice were infected with 4–20 i.n. ECTV LD<sub>50</sub>. (A, B) CPGs treatments with or without VA...
<p>A. Tumor volume (mm<sup>3</sup>) for each individual mouse, as measured from T<sub>2</sub>W MRI i...
<p>Relative mean fluorescence intensity changes as a function of time in the tumor tissue, outside t...
<p>Images were acquired at 20×magnification. Control – mice without treatment, Bleomycin – mice trea...
<p>The temporal profile of the mean FD fluorescence intensity in the tissue (extravascular compartme...
<p><b>(A)</b><i>In vivo</i> bioluminescence imaging of representative animals from each treatment gr...
<p>Time axis of experimental set up (<i>a</i>). 3×10<sup>6</sup> BM-DC were injected into C57BL/6 re...
SEV-ERAL authors have described how measurements of cell surviving fraction following bleomycin (BLM...
<p>After 11 days of tumor inoculation, tumors were touchable. Then mice were randomly regrouped (n =...
<p>(A) Growth of tumor volume in SE and EE mice, EE decreased tumor growth rate (n = 10–12 per group...
<p>Tumor growth was slower in mice fed the KD than in mice fed the SD. (A) Representative animals fr...
<p>Changes in uptake of <sup>18</sup>F-BCPP-EF (a) and <sup>18</sup>F-FDG (b), and in AI (c) in tumo...
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
<p>Time axis of experimental set up (<i>a</i>). 1.5×10<sup>6</sup> Thy1.1<sup>+</sup> P14 splenocyte...
<p>(A) 3D micro-CT imaging of progressive pulmonary fibrosis in a representative bleomycin-treated m...
<p>Mice were infected with 4–20 i.n. ECTV LD<sub>50</sub>. (A, B) CPGs treatments with or without VA...
<p>A. Tumor volume (mm<sup>3</sup>) for each individual mouse, as measured from T<sub>2</sub>W MRI i...
<p>Relative mean fluorescence intensity changes as a function of time in the tumor tissue, outside t...
<p>Images were acquired at 20×magnification. Control – mice without treatment, Bleomycin – mice trea...
<p>The temporal profile of the mean FD fluorescence intensity in the tissue (extravascular compartme...
<p><b>(A)</b><i>In vivo</i> bioluminescence imaging of representative animals from each treatment gr...
<p>Time axis of experimental set up (<i>a</i>). 3×10<sup>6</sup> BM-DC were injected into C57BL/6 re...
SEV-ERAL authors have described how measurements of cell surviving fraction following bleomycin (BLM...
<p>After 11 days of tumor inoculation, tumors were touchable. Then mice were randomly regrouped (n =...
<p>(A) Growth of tumor volume in SE and EE mice, EE decreased tumor growth rate (n = 10–12 per group...
<p>Tumor growth was slower in mice fed the KD than in mice fed the SD. (A) Representative animals fr...
<p>Changes in uptake of <sup>18</sup>F-BCPP-EF (a) and <sup>18</sup>F-FDG (b), and in AI (c) in tumo...
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
<p>Time axis of experimental set up (<i>a</i>). 1.5×10<sup>6</sup> Thy1.1<sup>+</sup> P14 splenocyte...
<p>(A) 3D micro-CT imaging of progressive pulmonary fibrosis in a representative bleomycin-treated m...
<p>Mice were infected with 4–20 i.n. ECTV LD<sub>50</sub>. (A, B) CPGs treatments with or without VA...
<p>A. Tumor volume (mm<sup>3</sup>) for each individual mouse, as measured from T<sub>2</sub>W MRI i...